Longevity / Liposomal NMN vs Capsule NMN: Bioavailability Evidence

Liposomal NMN vs Capsule NMN: Bioavailability Evidence

Written by

Sophie Chabloz

If you’ve shopped for NMN recently, you’ve seen “liposomal” claims promising dramatically higher absorption, often at significantly higher prices. The pitch is appealing: tiny lipid spheres ferry NMN past stomach acid, deliver more of the molecule into your bloodstream, multiply your dose. The evidence is weaker than the marketing implies. This piece sets out what liposomal delivery does, what the human data shows for NMN specifically, and why AVEA chose a standard HPMC capsule format.

In this article:

What “liposomal” delivery means
The general case for liposomal supplements
What the evidence shows for NMN specifically
Why standard capsule NMN works fine
The hidden trade-offs of liposomal formats
How AVEA approaches NMN delivery
Where to go next

What “liposomal” delivery means

A liposome is a microscopic sphere with a phospholipid bilayer wrapped around an aqueous core. Phospholipid bilayers are the same basic structure as cell membranes, which is why liposomes can fuse with cells and release their contents directly.

The theoretical case for liposomal supplements rests on two ideas. First, the lipid bilayer protects the encapsulated compound from stomach acid and digestive enzymes. Second, liposomes can fuse with cells (or be absorbed intact through the gut wall) and deliver their cargo to the bloodstream more efficiently than a free molecule.

For some compounds, both ideas hold up well. Liposomal vitamin C, for example, has reasonable evidence of improved blood levels at lower doses compared with standard ascorbic acid. Liposomal glutathione has clinical use because oral free glutathione is poorly absorbed without the protective shell.

The question for NMN is whether the same logic translates. The answer is more complicated.

The general case for liposomal supplements

Liposomal delivery improves bioavailability when three conditions are met. The compound is poorly absorbed in its free form. The compound is degraded in the stomach or intestine before absorption. And the liposomal carrier remains intact long enough to deliver its cargo across the gut wall.

For some lipid-soluble vitamins (D, K2) and some peptides, all three conditions are met and liposomal delivery makes a measurable difference. For water-soluble small molecules with their own absorption mechanisms, the case is weaker.

NMN is a water-soluble small molecule. It has dedicated transporters at the gut wall (Slc12a8) and is converted to NR or NAD+ inside enterocytes before entering circulation. The natural absorption pathway is reasonably efficient when the molecule is delivered in pharmaceutical-grade form.

What the evidence shows for NMN specifically

This is where marketing diverges from data. Across the published human trials of NMN, essentially all of the meaningful results come from standard capsule, tablet, or oral-powder formats. The first-in-human study (Irie et al., 2020) used an oral dose. Yoshino et al. 2021 used capsules. Pencina et al. 2023, the dose-response study at 300, 600, and 900 mg, used capsules. Igarashi et al. 2022 used oral capsules. None used liposomes.

There are a small number of studies on liposomal or otherwise enhanced NMN formulations. They tend to be sponsored by the manufacturers of those formats, use surrogate endpoints, and lack head-to-head comparison with standard capsules at equivalent doses. None has demonstrated a clinically meaningful advantage over a quality capsule NMN protocol.

Pharmacokinetic data tells a similar story. The peak blood NAD+ elevation, time-to-peak, and steady state achieved with capsule NMN at 250-500 mg per day is consistent with what you’d expect if the molecule is being absorbed efficiently. There’s no obvious bioavailability gap that liposomal delivery is filling.

Why standard capsule NMN works fine

Three reasons capsule format is sufficient for NMN.

First, NMN is reasonably stable in stomach acid for the brief period before it reaches the small intestine. Some degradation occurs, but the majority of an oral dose survives to be absorbed. The protection that liposomal encapsulation provides for more acid-sensitive molecules isn’t necessary here.

Second, NMN absorption uses dedicated transporters and the salvage pathway built into your gut wall. Your enterocytes are designed to take up nucleotides and nucleotide precursors. NMN fits this system without needing artificial delivery enhancement.

Third, the dose-response relationship in human trials shows clear NAD+ elevation at 250-500 mg of capsule NMN per day. If absorption were a real bottleneck, you’d expect flat or weak responses at these doses. You don’t see that. The cellular response appears to be limited more by transporter saturation at higher doses than by gastrointestinal absorption.

The implication: paying a premium for liposomal NMN is paying for a marketing format more than for a meaningful pharmacokinetic advantage. We cover the broader sourcing question at https://insights.avea-life.com/longevity/what-is-nmn-and-how-does-it-work/.

The hidden trade-offs of liposomal formats

Liposomal supplements aren’t free of downsides.

The cost premium is meaningful. Liposomal NMN typically costs 1.5 to 3 times what comparable capsule NMN costs, with no clear evidence of comparable improvement in outcomes.

The format constraints are real. Liposomes are typically suspended in liquid, which means liposomal supplements are usually liquid or gel formats with shorter shelf life and stricter storage requirements, often refrigeration. Capsules can sit on a shelf at room temperature for two years without degradation.

The verification gap is serious. With capsules, third-party testing can confirm the identity and purity of the NMN itself. With liposomal formats, there’s an additional question of whether the liposomes are intact, properly sized, and actually encapsulating the active ingredient. That’s harder to verify and rarely done by independent labs.

Then there’s taste and adherence. Liposomal liquid formulas often have an unpleasant phospholipid taste that some users describe as fishy or metallic. Capsules are flavour-neutral.

How AVEA approaches NMN delivery

AVEA NMN uses HPMC capsules. HPMC stands for hydroxypropyl methylcellulose, a plant-derived material that’s vegan, Halal certified, and dissolves cleanly in the stomach without affecting the contents.

The capsule contains pharmaceutical-grade Longevir NMN (greater than 99 percent purity, manufactured by Borealis Pharma in the Netherlands) and rice flour as the only excipient. No flow agents beyond what’s structurally necessary, no flavours, no liposomal carriers, no marketing-driven additions.

The case for this format: the molecule itself is what produces the effect. A clean delivery system gets the molecule into your stomach reliably, where your existing biology takes over. The 80 percent of users in our customer survey who reported energy and focus improvements at 30 days were on standard capsule NMN. The 43-year-old in our internal case study who doubled intracellular NAD+ in three weeks was on standard capsule NMN.

The simplicity isn’t a compromise. It’s a choice based on what the molecule needs and what the evidence supports. We cover the broader review at https://insights.avea-life.com/longevity/avea-supplement-review-does-avea-nmn-booster-actually-really-work/.

Where to go next

If you want the broader buyer’s guide to NMN quality, How to choose a high-quality NMN supplement: purity, sourcing, third-party testing covers the practical evaluation criteria. To compare NMN with other precursors, “NAD+ precursors compared: NMN, NR, niacin, NAM” goes through the side-by-side. And “NAD+ Decline and How to Restore It” brings the full picture together.